Literature DB >> 33931768

Belzutifan has potential in RCC.

Diana Romero1.   

Abstract

Entities:  

Year:  2021        PMID： 33931768     DOI： 10.1038/s41571-021-00517-w

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis.

Authors:  Toni K Choueiri; Todd M Bauer; Kyriakos P Papadopoulos; Elizabeth R Plimack; Jaime R Merchan; David F McDermott; M Dror Michaelson; Leonard J Appleman; Sanjay Thamake; Rodolfo F Perini; Naseem J Zojwalla; Eric Jonasch
Journal:  Nat Med       Date:  2021-04-22       Impact factor: 87.241
  1 in total
  1 in total

Review 1.  HIF in Gastric Cancer: Regulation and Therapeutic Target.

Authors:  Mengqing Li; Guan Li; Xiaodong Yang; Weihua Yin; Guoqing Lv; Shubin Wang
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.